Immunome (IMNM) CAPEX/Revenue US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
CAPEX/Revenue, % | 5.93% | 22.8% | ||||||
Changes by years, y/y, % |
Immunome. CAPEX/Revenue, %
Immunome. CAPEX/Revenue, changes, pp
Immunome (IMNM) CAPEX/Revenue US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
CAPEX/Revenue, % | 4.48% | 7.98% | 1.01% | 9.12% | 210.3% | 22.8% | ||
Changes by years, y/y, % | +206pp | |||||||
Changes by quarters, q/q, % | +3pp | -7pp | +8pp | +201pp |